Study clarifies surgical options for kidney cancer

July 24, 2013

Surgery is often the first step in treating kidney cancer, and new data from the University of Rochester Medical Center, which contradicts earlier research, questions whether removal of only the tumor (partial nephrectomy) is better than removing the entire kidney (radical nephrectomy).

The decided trend for the past decade has been toward a partial resection in the case of smaller cancers. It was based on several earlier studies suggesting that it's better to save as much as possible, and thus preserve and reduce the likelihood of in the long run. Many physicians inferred that a would be worse for , due to a concern that even mild or moderate dysfunction in the remaining kidney could lead to an earlier death.

However, the URMC found the opposite to be true: that losing a whole kidney to surgery does not translate into poorer outcomes for patients. In fact, those people who received a did not have improved survival, according to the study published this month in European Urology.

"Our data appears to seriously question the assumption that by saving kidney tissue, we are helping patients avoid future kidney failure," said Edward Messing, M.D., chair of Urology at URMC. "It may be that losing kidney tissue from surgery is not the same as losing kidney function from medical diseases like diabetes or hypertension."

The latter point is an important one for patients who're weighing , Messing added. Often, all types of kidney impairments are lumped into one category. It may be, however, that common medical conditions such as or diabetes take the biggest toll on kidney health. Therefore, if a patient is otherwise healthy and the second kidney is functioning well, he or she can safely consider a radical nephrectomy, if that seems to be the best option for cancer removal, he said.

Emelian N. Scosyrev, Ph.D., an and assistant professor of Urology, led the analysis of more than 500 patients registered by the European Organization for Research and Treatment of Cancer randomized trial from 1992 to 2003.

In collaboration with the EORTC investigators, Scosyrev looked at various stages of renal dysfunction based on the EORTC trial data. Specifically researchers compared the incidence of moderate , advanced kidney disease, and kidney failure among two groups: 255 people who were treated with a partial nephrectomy and 259 patients who had a radical nephrectomy. The latter surgery removes the entire organ, adrenal gland, and surrounding tissue. All patients had been diagnosed with a small kidney cancer and had a normal-functioning second kidney.

The URMC trial analyzed each patient's kidney function for a median of seven years after surgery, and continued to follow the cohort for approximately nine years, to determine the impact of both surgeries on patient survival.

At the median follow-up of 6.7 years, the frequency of moderate kidney dysfunction was 20% lower among those patients who received a partial nephrectomy, compared with those randomized to a radical nephrectomy. However, the better overall kidney function in the partial nephrectomy group did not result in improved survival. Indeed, at the last follow-up point of about nine years, fewer deaths had occurred in the radical nephrectomy group, the study showed.

Kidney failure was the same in both groups, at about 1.5 percent. This outcome was a bit surprising, Messing said, as it demonstrated that patients in the radical nephrectomy group who had initially suffered a mild or moderate degree of kidney dysfunction did not see their condition progress to kidney failure. When choosing a surgery, therefore, it's important to consider the best option for removing the cancer in the broader context of other medical conditions that impact kidneys.

The most common type of kidney cancer is renal cell carcinoma, which forms in the lining of the tubes that filter blood and remove waste. An estimated 65,000 new cases of will be diagnosed in the United States this year, and approximately 13,700 deaths are expected to occur, according to the National Cancer Institute.

Explore further: Kidney cancer patients do better when whole kidney is not removed

More information:

Related Stories

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.